Related Experiment Video
Updated: Mar 1, 2026
05:16
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
692
Biomarkers in heart failure
1Salvatore Maugeri Foundation, Scientific Institute of Veruno, Novara, Italy. ermanno.eleuteri@fsm.it
Minerva Cardioangiologica
|April 13, 2012
Summary
Biomarkers are crucial for diagnosing heart failure. While no single perfect biomarker exists, combining various markers may improve diagnosis and treatment efficacy for this complex condition.
Area of Science:
- Biomedical Science
- Clinical Diagnostics
- Cardiovascular Research
Background:
- Biomarkers are objectively measured characteristics indicating biological processes or responses to treatment.
- Heart failure diagnosis is complex, necessitating improved diagnostic tools.
- Existing research has identified various biomarker categories for chronic heart failure.
Purpose of the Study:
- To review and categorize existing and emerging biomarkers for heart failure.
- To discuss the challenges and future directions in heart failure biomarker discovery.
- To highlight the potential of combining biomarkers for improved diagnostic accuracy.
Main Methods:
- Literature review of pathophysiologic biomarkers for heart failure.
- Categorization of biomarkers based on underlying biological processes (inflammation, oxidative stress, etc.).
- Discussion of factors influencing biomarker utility (sensitivity, specificity, cost).
Main Results:
- Multiple categories of heart failure biomarkers have been identified, including inflammation, oxidative stress, extracellular-matrix remodeling, neurohormones, and myocyte injury/stress.
- No single ideal biomarker currently exists for heart failure.
- Combining multiple biomarkers may offer a more comprehensive diagnostic approach.
Conclusions:
- The search for ideal heart failure biomarkers is ongoing, with potential in both new and overlooked markers.
- Integrating diverse molecular information through combined biomarkers may overcome individual test limitations.
- Advancements in genomics, proteomics, and metabolomics promise a continuous discovery of novel heart failure biomarker candidates.
More Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
5.9K
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
17.2K
Related Concept Videos
01:30Heart Failure VII: Nursing Interventions
599
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
599
01:26Heart Failure III: Clinical Manifestations
719
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
719
01:29Heart Failure II: Pathophysiology
1.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
655
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
655
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
1.0K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.0K
01:17Pathophysiology of Heart Failure
4.2K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.2K